Aims: Increased levels of homocysteine (Hcy) form an independent risk factor for cardiovascular disease. In a previous study we have shown that Hcy induced phosphatidylserine (PS) exposure to the outer leaflet of the plasma membrane in cardiomyocytes, inducing a pro-inflammatory phenotype. In the present study the mechanism(s) involved in Hcy-induced PS exposure were analyzed. Methods: H9c2 rat cardiomyoblasts were subjected to 2.5 mM D,L-Hcy and analyzed for RhoA translocation and activity, Rho Kinase (ROCK) activity and expression and flippase activity. In addition, the effect of ROCK inhibition with Y27632 on Hcy-induced PS exposure and flippase activity was analyzed. Furthermore, GTP and ATP levels were determined. Results: Incubation of H9c2 cells with 2.5 mM D,L-Hcy did not inhibit RhoA translocation to the plasma membrane. Neither did it inhibit activation of RhoA, even though GTP levels were significantly decreased. Hcy did significantly inhibit ROCK activation, but not its expression, and did inhibit flippase activity, in advance of a significant decrease in ATP levels. ROCK inhibition via Y27632 did not have significant added effects on this. Conclusion: Hcy induced PS exposure in the outer leaflet of the plasma membrane in cardiomyocytes via inhibition of ROCK and flippase activity. As such Hcy may induce cardiomyocytes vulnerable to inflammation in vivo in hyperhomocysteinaemia patients.
Introduction
Homocysteine (Hcy) is an amino acid derived from the methionine metabolism and is normally remethylated to methionine or otherwise converted to cysteine. Due to either genetic mutations in the converting enzymes or due to shortages of vitamin B6, B12 or folate which are important co-factors in the metabolism, Hcy levels can rise [1] . For instance, genetic mutations in the cysthatione β-synthase (CBS) gene can result in highly increased Hcy plasma levels of up to 400 µM, which is known as hyperhomocystinuria [2] . These patients usually develop severe cardiovascular complications as young adults. Most patients however suffer from moderately increased levels of Hcy, known as hyperhomocysteinaemia (HHC) which are mostly caused by co-factor shortages. Population studies have revealed that HHC, even in mild forms can be an independent risk factor for the development of atherosclerosis and heart failure [3] [4] [5] . HHC has been shown to induce heart failure including diastolic and systolic dysfunction, with myocardial fibrosis and subsequent ventricular hypertrophy and increased wall thickness [5] [6] [7] . The mechanisms underling this HHC-induced heart failure however remain for a large part unknown.
Previously we have demonstrated that Hcy induced apoptosis and necrosis, but also reversible exposure of phosphatidylserine in the outer plasma membrane leaflet in cardiomyocytes (PS exposure) [8] . In eukaryotic cells plasma membrane phospholipids are distributed asymmetrically in the bilayer. The outer leaflet predominantly contains phosphatidyl-choline (PC), whereas anionic PS and phosphatidyl-ethanolamine (PE) are kept within the inner leaflet [9] . Exposure of PS in the outer plasma membrane leaflet occurs in apoptotic cells, but can also be reversible and occur independently of apoptosis [10] . Exposed PS becomes a target for inflammation, and we have shown previously that in the presence of inflammation, reversible PS exposure can result in additional cardiomyocyte death after myocardial infarction [11, 12] . This Hcy-induced (reversible) PS exposure by cardiomyocytes, thereby facilitating local inflammation and resulting cardiomyocyte death, potentially also is a contributing factor to HHC-induced heart failure.
We have recently found that inhibition of Rho -ROCK signaling induced both apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase [13] . Flippase is an ATP-dependent transmembrane protein that has been found to regulate transbilayer phospholipid asymmetry also in cardiomyocytes, by translocating PS from the outer to the inner membrane layer [14] . This study showed a regulatory role for a novel signaling route, Rho -ROCK -flippase signaling, in maintaining asymmetrical membrane phospholipid distribution in cardiomyocytes. In the present study we have investigated the possible involvement of this signaling route in Hcy-induced PS exposure in cardiomyocytes.
Materials and Methods

Cell culture
Rat cardiomyoblasts (H9c2 (2-1) cells; ATCC, Manassas, VA, USA) were cultured in Dulbecco's Modified Eagles Medium (DMEM; BioWhittaker, Verviers, Belgium) supplemented with 10% heat-inactivated fetal calf serum (FCS; BioWhittaker), 2 mM L-glutamine (GIBCO, Paisley, UK), 100 IU/ml penicillin (Yamanouchi Europe BV, Leiderdorp, Netherlands) and 100 µg/ ml streptomycin (Radiopharma-Fisiopharma, Palomonte, Italy), and grown at 37°C in a humidified 5% CO 2 /95% air atmosphere. Experiments were performed with cells grown to a confluency of 60 -80%. Cells were incubated with 2.5 mM D,L-homocysteine (Hcy) (Sigma, St. Louis, MO, USA) in growth medium for 14, 18 or 24 hours at 37°C in a humidified 5% CO 2 /95% air atmosphere, according to our previous study [8] . Cells were incubated with ROCK inhibitor 10 μM Y27632 (Calbiochem, Nottingham, UK) for 24.5 hours at 37°C in a humidified 5% CO 2 /95% air atmosphere. In case cells were co-incubated with Y27632 and Hcy, Y27632 was added to cells 30 minutes prior to Hcy.
Flow cytometry
PS exposure was assessed with FITC-labeled human recombinant annexin-V (Bender Med Systems, Vienna, Austria), while propidium iodide (PI; Bender Med Systems) was used to determine the permeability of the cellular membrane. Experiments were performed in the presence or absence of ZAsp-Glu-Val-Asp-fluoromethylketone (Z-VAD FMK, 25 μM, Alexis Biochemicals, Lausen, Switzerland), a general caspase inhibitor, to differentiate between reversible and irreversible PS exposure.
After treatment with Hcy, the cells were trypsinized and centrifuged at 400xg for 5 minutes at room temperature. Cells were then washed with serum-free DMEM, and resuspended in serum free DMEM containing annexin V (1:40) for 30 minutes in the dark at 37°C in a humidified 5% CO 2 /95% air atmosphere. Cells were subsequently washed and resuspended in serum free DMEM containing PI (1:40), and were measured with a FACSCalibur (Becton Dickinson, San Jose, CA, USA). Results were analyzed by Cell Quest Pro software (Becton Dickinson).
To determine flippase activity, cells were harvested after incubation with or without Hcy and resuspended in serum free DMEM medium. NBD labeled phosphatydylserine (PS-NBD:
Lipids, Alabaster, AL, USA) was added in a final concentration of 1 μmol/L at 37°C for 30 minutes. The cells were then transferred to ice and 5 ml ice-cold 1% (w/v) BSA in PBS added to wash away excess probe. After 15 minutes the cells were pelleted and resuspended in serum-free culture medium and then analyzed by flow cytometry (FACSCalibur). With each experiment, part of the harvested cells were analyzed for membrane flip flop as described before.
To determine whether the PS-NBD negative cells are in fact annexin V positive, the cells were labeled with Cy5-labeled annexin V for 15 minutes at 37°C subsequent to PS-NBD staining and measured at once as described before.
Determination of ATP and GTP levels
After treatment, 5 x 10E6 cells per condition were centrifuged at 400 x g for 2 minutes. The pellet was resuspended in 150 µl of ice-cold perchloric acid (PCA) 0.4 M, kept on ice for 30 minutes and subsequently centrifuged at 200 x g for 5 minutes at 4°C. To the isolated supernatant 7.5 µl of K 2 CO 3 5 M was added to neutralize pH. Samples were subsequently stored at -80°C. ATP levels were determined using a Luciferase-Luciferin assay (Biaffin GmbH & Co KG, Kassel, Germany) according to the manufacturers' protocol. Samples were analyzed in a FluoroNunc MaxiSorp plate (Nalge Nunc International, Rochester, NY). Luminescence was measured in a Tecan GENios Plus reader (Tecan Benelux, Mechelen, Belgium). GTP levels were determined using High Pressure Liquid Chromatography (HPLC) as described before [15] . The columns used were prepacked Partisphere (partisil-5) SAX cartridges (4.6 x 125 mm internal dimensions; Whatman Int. Ltd., Maidstone England). The GTP concentrations were calculated by comparison with highly purified standards (Sigma).
RhoA activity assay
RhoA activity was determined in H9c2 cell protein extracts, using the luminescence-based G-LISA TM RhoA activation assay biochemistry kit (Cytoskeleton, Inc. Denver, CO, USA) according to the manufacturer's instructions. Protein concentration was determined according to the manufacturer's protocol, and cell extracts were equalized. Samples were measured in a FluoroNunc MaxiSorp plate (Nalge Nunc International).
Cell fractioning and Western Blot analysis
For whole cell lysates, cells were harvested into modified ELB lysis buffer (250 mM NaCl, 0.1% Nonidet P-40, 50 mM HEPES pH 7.0, 5 mM EDTA, 0.5 mM DTT) with added protease inhibitor cocktail (PIC, 1:25; Sigma), mixed thoroughly and then incubated on ice for 30 minutes. To obtain membrane and cytosolic fractions, cells were harvested into lysis buffer (5 mM Tris, 1 mM EDTA, 5 mM MgCl 2 ) and homogenized using a dounce tissue grinder (Wheaton, Millville, NJ, USA). Samples were centrifuged at 500 x g for 5 minutes at 4°C. The supernatant was then centrifuged at 40,000 rpm using a Beckman centrifuge (50 Ti rotor; BeckmanCoulter, Mijdrecht, The Netherlands) for 20 minutes at 4°C to separate the membrane fraction (pellet) from the cytosolic fraction (supernatant). The membrane fraction was dissolved in incubation buffer (25 mM Tris, 1 mM EGTA, 20 mM MgCl 2 ). After determination of the protein concentration with the BCA protein assay kit (Pierce, Rockford, IL, USA), the samples were diluted in β-mercaptoethanol-containing sodium dodecylsulfate (SDS) sample buffer. 20 μg protein of each sample was then subjected to SDS-PAGE, blotted onto nitrocellulose membranes and analyzed for RhoA, ROCK-1 and ROCK-2 expression using mAb against RhoA (26c4; 1:100 dilution; Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA), mAb against ROCK-1 (G-6; 1:250 dilution; Santa Cruz) or pAb (goat) against ROCK-2 (C-20; 1:400 dilution; Santa Cruz), followed by horseradish-peroxidase-conjugated rabbit-antimouse immunoglobulins (RαM-HRP; 1:1000 dilution; DakoCytomation, Glostrup, Denmark) for RhoA and ROCK-1 or Swine-anti-Goat-HRP (1:500 dilution; DakoCytomation) for ROCK-2. The blots were visualized by enhanced chemiluminescence (ECL; Amersham Biosciences AB; Uppsala; Sweden). Staining was quantified with a charge-coupled device camera (Fuji Science Imaging Systems; Düsseldorf, Germany) in combination with AIDA Image Analyzer software (Isotopenmessgeräte; Staubenhardt, Germany). For detection of total and phosphorylated ezrin, radixin and moesin (ERM) proteins, rabbit pAbs against total ERM and phospho-ERM were used (both 1:1000 dilution; Cell Signaling Technology, Inc) followed by swine-anti-rabbit-HRP (1:1000; DakoCytomation).
Digital imaging fluorescent microscopy of RhoA
Cells were cultured in Lab-Tek II 4-well chamber CC2 glass slides (Nalge Nunc International, Naperville, IL, USA). After 
Statistics
Statistics were performed with the SPSS statistical program (windows version 15.0). To evaluate whether observed differences were significant, independent student T-tests or One Way ANOVA with post hoc Bonferroni tests were used.
In the text and relevant figures values are given as means ± SD. A p-value (two-sided) of 0.05 or less was considered to represent a significant difference. 
Results
Hcy induced PS-exposure
We first wanted to validate our previous finding of induced PS exposure in H9c2 cells by 2.5 mM D,L-Hcy for 24 hours [8] . We found a significant decrease of viable cells from 77.5 ± 2.4% in control cells to 54.9 ± 3.7% in Hcy treated cells ( Fig. 1A ; *p<0.0001; n=10) and a significant increase of single annexin V-positive cells from 5.8 ± 1.2% in control cells to 20.6 ± 2.2% in Hcy treated cells ( Fig. 1B ; *p<0.0001; n=10). We also found a significant increase in annexin V/PI-positive cells from 13.8 ± 1.4% in control cells to 20.9 ± 2.5% in Hcy treated cells ( Fig. 1C; *p<0 .02) and a minor, non-significant increase of single PI-positive cells from 1.7 ± 0.3% in control cells to 3.2 ± 1.0% in Hcy treated cells (Fig. 1D) . The induction of single annexin V-positive cells induced by Hcy was not inhibited by Z-VAD fmk (data not shown), this indicates reversible PS exposure, as shown previously [8] .
Effect of Hcy on RhoA location and activity
We have recently found that inhibition of Rho protein activity by Toxin B and exoenzyme C3 transferase resulted in PS exposure in H9c2 cells [13] . To determine whether Hcy-induced PS-exposure results from an effect on Rho -ROCK signaling, we first examined whether Hcy affects RhoA translocation -via cell fractioning -and activity -via cellular GTP measurements and a RhoA activity assay.
In control cells, RhoA was mainly present in the cytosolic fraction ( Fig. 2A, B ; intensity of the bands was defined as light arbitrary units (Lau); n=4). Notably, via immunoblotting two bands were detected, indicative for RhoA (24 kD) and the calpain cleaved form RhoA (20 kD), which has lost its normal RhoA function as described before [16] . For this, we only quantified the 24 kD RhoA band. Hcy induced a non-significant decrease in RhoA in the cytosolic fraction and a clear but nonsignificant increase in RhoA in the membrane fraction ( Fig. 2A, B) , indicating that Hcy did not inhibit RhoA translocation to the plasma membrane. Although the Hcy effects were not significant, we found this Hcy-induced RhoA translocation to the membrane fraction in each of the four independent experiments. These results were confirmed via digital imaging fluorescent microscopy (Fig.  2C) . In control cells, RhoA was found mainly in the cytosol, whereas Hcy induced a marked increase in RhoA located at the plasma membrane (arrowheads).
In addition to membrane-anchorage, RhoA needs GTP for its activity. We therefore also determined the effects of Hcy on cellular GTP levels. Incubation with Hcy induced cellular GTP levels to decrease significantly from 437 pmol/10 Fig. 2D; p=0.05; n=4 ). Notwithstanding this decrease there was still considerable residual cellular GTP. To analyze whether this residual GTP still is sufficient for RhoA activation, a RhoA activity assay was performed. RhoA activity in cells incubated with Hcy did not differ significantly from control cells ( Fig. 2E; n=3) . From these data we can conclude that Hcy does not inhibit RhoA. 
Effect of Hcy on ROCK activity
ROCK is a downstream effector of RhoA. Previously we have shown that inhibition of Rho-kinase with the specific ROCK inhibitors Y-27632 and H1152 induced PS exposure in non-ischemic cardiomyocytes [13] . We analyzed a putative effect of Hcy on ROCK activity and expression. As ROCK phosphorylates the ezrin, radixin and moesin (ERM) proteins [17] , Rho-kinase activity can be determined by measuring the level of phosphorylation of ERM (pERM).
Incubation with Hcy for 24 hours induced a significant decrease of 45% in ERM phosphorylation (Fig.  3A, B ; SD ± 9.540; *p=0.002; n=4), determined as the relative amount of phosphorylyzed ERM (pERM) related to the total amount of ERM (tERM). These data thus indicate that Hcy inhibits ROCK activity. This inhibitory effect of Hcy on ROCK activity may relate to an inhibitory effect on ROCK expression. Therefore, ROCK-1 and ROCK-2 expression levels were analyzed via Western blot. There was no significant effect of Hcy on the expressions of ROCK-1 and ROCK-2, although Hcy treatment appeared to lower the expression levels of ROCK-2 (Fig. 3C) .
In addition, the effect of (pre-)inhibition of ROCK on Hcy-induced PS exposure was analyzed, using the ROCK inhibitor Y27632. As reported previously [13], Y27632 induced a significant increase in single-annexin V-positive cells to 19.9 ± 2.6% compared to 8.1 ± 2.1% in control cells (*p<0.05; Fig. 3D ). Y27632 pre-treatment followed by Hcy incubation also induced a significant increase in single-annexin V-positive cells to 23.9 ± 1.8% ( †p<0.05), but this percentage of single-annexin V-positive cells did not differ significantly from that induced by Y27632 alone. The percentage of single-annexin Vpositive cells induced by Hcy alone (30.4 ± 3.1%; ‡p<0.001 vs control) was higher than those induced by Y27632 alone or Y27632 followed by Hcy, but not significantly. These results support a role for ROCK inhibition in Hcy-induced exposure of PS.
Effect of Hcy on flippase activity
We then wanted to determine whether the inhibitory effect of Hcy on ROCK activity also affected flippase activity. Flippase activity was determined by flow cytometry analysis using NBD-labeled PS. In cells with flippase activity this PS-NBD is internalized resulting in PS-NBD-positive cells, whereas cells with inactive flippase will not internalize PS-NBD and remain PS-NBD-negative [13] (Fig. 4A) .
Hcy induced a significant increase in the amount of PS-NBD-negative cells, form 16 ± 3% in control cells to 27 ± 4% ( Fig. 4B ; *p=0.033; n=10), indicating that Hcy significantly decreased flippase activity. In addition, the effect of (pre-)inhibition of ROCK on Hcy-induced flippase activity was analyzed. Y27632 induced a significant increase in PS-NBD-negative cells to 32.1 ± 3.3% compared to 17.3 ± 1.8% in control cells (*p<0.05; Fig. 4C ). Y27632 pre-treatment followed by Hcy incubation also induced a significant increase in PS-NBDnegative cells to 36.3 ± 4.8% ( †p<0.01), but this percentage of PS-NBD-negative cells did not differ significantly from that induced by Y27632 alone, again supporting a role for ROCK inhibition in Hcy-induced inhibition of flippase.
As flippase activity is ATP dependent [18] , we analyzed whether Hcy-induced flippase activity is caused by ATP. Flippase activity and cellular ATP levels were determined at several time points during the total Hcy incubation period of 24 hours. A significant decrease in flippase inactivity was measured after 14 hours of Hcy incubation ( Fig. 5A ; *p<0.01), at which time-point cellular ATP levels were comparable with those in control cells (Fig. 5B) . A significant decrease in cellular ATP occurred only after 18 hours of Hcy incubation ( Fig. 5B; *p<0.05) . Therefore, Hcy-induced flippase inhibition is not due to a lack in cellular ATP.
To establish whether this flippase inactivation coincided with PS exposure, double stainings were performed with PS-NBD and Cy5-labbeled annexin V. Incubation with Hcy indeed resulted in a population of Cell Physiol Biochem 2011;28:53-62 Homocysteine-induced Phosphatidylserine Exposure in Cardiomyocytes cells that were PS-NBD negative but annexin V-positive ( Fig. 6 ; *p=0.022; n=4), indicating that Hcy-induced flippase inactivity coincided with PS exposure.
Discussion
We were the first to describe that Hcy induced apoptosis, necrosis but also reversible PS exposure in cardiomyocytes [8] . In the present study, we analyzed the mechanism(s) through which Hcy induced this PS exposure in cardiomyocytes. We have found that Hcy induced inhibition of Rho-kinase activity and flippase activity (Fig. 7) which to the best of our knowledge has never been described before.
In a previous study we found that impaired Rho -ROCK signaling resulted in PS exposure in the outer plasma membrane leaflet in cardiomyocytes [13] . This concurs with the findings of Grounds et al. who showed that inhibition of Rho activity by the Rho(A,B,C) specific inhibitor exoenzym C3 transferase induced annexin V positivity [19] . In the present study however we found that although Hcy did induce RhoA translocation to the plasma membrane, it did not alter RhoA activity, indicating that the Hcy-induced PS exposure occurred independent of impaired RhoA. On the other hand, Hcy did inhibit ROCK activity resulting in decreased phosphorylation of the ERM proteins. As Hcy did not significantly decrease the expression of ROCK-1 and ROCK-2, this inhibitory effect of Hcy on ROCK activity appears to be due mainly to blocking of its activity. Since Hcy did appear to lower the expression levels of ROCK-2, we cannot rule out a partial effect of decreased ROCK-2 expression on Hcyinduced ROCK inactivation. Previously we showed that inhibition of ROCK via Y27632 or H1152 did lead to PS exposure [13] . Here we show that inhibition of ROCK via Y27632, did not significantly affect Hcy-induced PS exposure, indeed supporting a role for ROCK inhibition in Hcy-induced PS exposure.
As we have previously shown, PS exposure represents a pro-inflammatory status of the cell [12] . This suggests that Hcy induced inhibition of Rho-kinase would put cardiomyocytes at risk as targets for inflammation. In the past several rat and mice in vivo studies have been performed in which the effect of commercially available ROCK inhibitors was analyzed related to the prevention of vascular endothelial disease independent of Hcy [20] [21] [22] [23] . However, in none of these studies the effect on PS exposure in cardiomyocytes and/or replacement fibrosis was studied as a measure of putative loss of cardiomyocytes. Therefore, our in-vitro findings suggesting a jeopardizing effect of inhibition of Rho-kinase on cell viability of cardiomyocytes still have to be extrapolated in-vivo.
Hcy inhibited flippase activity in cardiomyocytes, in advance of a decrease in ATP, suggesting that Hcy does so through mechanisms independent of ATP. We have shown earlier that ROCK inhibitors Y27632 and H1152 did inhibit flippase activity without altering cellular ATP levels [13] . In this study we additionally show that inhibition of ROCK via Y27632, did not significantly affect Hcy-induced inhibition of flippase activity. This suggests that Hcy inhibits flippase via its inhibitory effect on ROCK.
A limitation of the present study is the use of relatively high concentrations of Hcy. However, in our 
